FOLH1 and neoplasm: However, the relatively low binding affinity and excessive hydrophilicity of [177Lu]Lu-PSMA-4PY lead to low uptake in tumors and rapid clearance of [177Lu]Lu-PSMA-4PY, not only from blood and normal organs, but also from the tumor, resulting in undesirable therapeutic efficacy.